HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark P Boldin Selected Research

Mark P Boldin Research Topics

Disease

6Inflammation (Inflammations)
01/2021 - 01/2002
4Neoplasms (Cancer)
11/2017 - 01/2007
3Infections
01/2021 - 02/2007
1Neuroinflammatory Diseases
01/2022
1Cytokine Release Syndrome
01/2020
1Hypersensitivity (Allergy)
01/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2020
1Splenomegaly
01/2017
1Bone Marrow Failure Disorders
01/2017
1Breast Neoplasms (Breast Cancer)
04/2014

Drug/Important Bio-Agent (IBA)

5MicroRNAs (MicroRNA)IBA
11/2017 - 01/2007
2NF-kappa B (NF-kB)IBA
10/2014 - 05/2011
1LipopolysaccharidesIBA
01/2022
1Interleukin-8 (Interleukin 8)IBA
01/2021
1ChemokinesIBA
01/2021
1Green Fluorescent ProteinsIBA
01/2021
1InterferonsIBA
01/2021
1Cell-Penetrating PeptidesIBA
01/2021
1Chimeric Antigen ReceptorsIBA
01/2020
1Interleukin-1 (Interleukin 1)IBA
01/2020
1OligonucleotidesIBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
01/2017
1Interleukin-1 Receptor-Associated KinasesIBA
10/2014
1Proteins (Proteins, Gene)FDA Link
10/2014
1Zonula Occludens-1 ProteinIBA
04/2014
1Transcription Factors (Transcription Factor)IBA
03/2012
1LigandsIBA
01/2002

Therapy/Procedure

1Intranasal Administration
01/2021
1Injections
01/2020